127 related articles for article (PubMed ID: 38734848)
1. Plexin B2 tissue expression and related gene polymorphisms in psoriasis and their relation to NB-UVB and Acitretin therapy.
Hegazy EM; Taieb MAE; Hassan MH; Ibrahim AK; El-Din EA; Ibrahim HM
Arch Dermatol Res; 2024 May; 316(5):162. PubMed ID: 38734848
[TBL] [Abstract][Full Text] [Related]
2. Narrow band ultraviolet-B versus Goeckerman therapy for psoriasis with and without acitretin: A retrospective study.
Çalıskan E; Tunca M; Açıkgöz G; Arca E; Yürekli A; Akar A
Indian J Dermatol Venereol Leprol; 2015; 81(6):584-7. PubMed ID: 26515836
[TBL] [Abstract][Full Text] [Related]
3. Plexin-B2 in psoriasis; a clinical and immunohistochemical study.
Hemida AS; Mareae AH; Elbasiony ASA; Shehata WA
J Immunoassay Immunochem; 2020 Jul; 41(4):718-728. PubMed ID: 32186222
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of combination treatment with narrowband UVB (TL-01) and acitretin vs narrowband UVB alone in plaque-type psoriasis: a retrospective study.
Kampitak T; Asawanonda P
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S20-4. PubMed ID: 17718265
[TBL] [Abstract][Full Text] [Related]
5. Plasma miR-126 expression correlates with risk and severity of psoriasis and its high level at baseline predicts worse response to Tripterygium wilfordii Hook F in combination with acitretin.
Duan Y; Zou J; Mao J; Guo D; Wu M; Xu N; Zhou J; Zhang Y; Guo W; Jin W
Biomed Pharmacother; 2019 Jul; 115():108761. PubMed ID: 31100542
[TBL] [Abstract][Full Text] [Related]
6. TWEAK levels in psoriatic patients treated with narrowband ultraviolet B and methotrexate.
Hegazy EM; El Taieb MA; Ibrahim HM; Rageh EM; Ahmed NM; Ibrahim AK; Younis AM; Ali MA
J Cosmet Dermatol; 2024 May; 23(5):1905-1911. PubMed ID: 38299446
[TBL] [Abstract][Full Text] [Related]
7. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
8. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis.
Short MW; Vaughan TK
Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760
[TBL] [Abstract][Full Text] [Related]
9. The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris.
Antiga E; Volpi W; Chiarini C; Cardilicchia E; Filì L; Manuelli C; Parrochi P; Fabbri P; Caproni M
Int J Immunopathol Pharmacol; 2010; 23(3):767-74. PubMed ID: 20943046
[TBL] [Abstract][Full Text] [Related]
10. Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin.
Zhang CS; Yang L; Zhang AL; May BH; Yu JJ; Guo X; Lu C; Xue CC
J Altern Complement Med; 2016 Mar; 22(3):174-88. PubMed ID: 26919330
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
12. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
[TBL] [Abstract][Full Text] [Related]
13. IL17A and IL17F Gene Polymorphism Association with Psoriasis Risk and Response to Treatment in a Polish Population.
Białecka M; Ostasz R; Kurzawski M; Klimowicz A; Fabiańczyk H; Bojko P; Dziedziejko V; Safranow K; Machoy-Mokrzyńska A; Droździk M
Dermatology; 2016; 232(5):592-596. PubMed ID: 27591988
[TBL] [Abstract][Full Text] [Related]
14. Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis.
Yelverton CB; Yentzer BA; Clark A; Pearce DJ; Balkrishnan R; Camacho FT; Boles A; Fleischer AB; Feldman SR
Arch Dermatol; 2008 Sep; 144(9):1224-5. PubMed ID: 18794474
[No Abstract] [Full Text] [Related]
15. A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis.
Lee JH; Youn JI; Kim TY; Choi JH; Park CJ; Choe YB; Song HJ; Kim NI; Kim KJ; Lee JH; Yoo HJ
BMC Dermatol; 2016 Jul; 16(1):11. PubMed ID: 27455955
[TBL] [Abstract][Full Text] [Related]
16. Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis.
Lebwohl M; Drake L; Menter A; Koo J; Gottlieb AB; Zanolli M; Young M; McClelland P
J Am Acad Dermatol; 2001 Oct; 45(4):544-53. PubMed ID: 11568745
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial.
Caproni M; Antiga E; Melani L; Volpi W; Del Bianco E; Fabbri P
J Clin Immunol; 2009 Mar; 29(2):210-4. PubMed ID: 18763027
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of tissue levels of serine protease inhibitor (vaspin) in psoriasis vulgaris patients: a possible mechanism of narrowband ultraviolet B radiation.
Sayed KS; Said ER; Mohammed FN; Algorhary M; Rashed LA
Arch Dermatol Res; 2019 Oct; 311(8):637-641. PubMed ID: 31292731
[TBL] [Abstract][Full Text] [Related]
19. Optimizing acitretin use in patients with plaque psoriasis.
Chiricozzi A; Panduri S; Dini V; Tonini A; Gualtieri B; Romanelli M
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27998019
[TBL] [Abstract][Full Text] [Related]
20. Acitretin in combination with UVB or PUVA.
Lebwohl M
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 2):S22-4. PubMed ID: 10459143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
